Format

Send to

Choose Destination
J Pediatr. 1995 Dec;127(6):1002-5.

Safety of lidocaine-prilocaine cream in the treatment of preterm neonates.

Author information

1
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

Abstract

The safety of lidocaine-prilocaine cream (EMLA) was evaluated in an open trial in 30 preterm neonates (mean gestational age, 32.8 weeks; birth weight, 1911 gm); 0.5 gm was applied to the heel for 1 hour. Mean baseline and follow-up (4, 8, or 12 hours after EMLA application) methemoglobin levels were not different, ranging from 1.15% to 1.45%, and from 1.13% to 1.49%, respectively.

PMID:
8523173
DOI:
10.1016/s0022-3476(95)70050-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center